Who Owns CNTB?

Connect Biopharma Holdings Limited — Institutional Ownership & 13F Holdings

$2.49

+0.09 (+3.75%)

Market Cap

$148.1M

Shares Outstanding

56,521,282

Institutional Holders

13

Total Inst. Value

$1.6M

% of Float Held

QoQ Holder Change

+1

Institutional data as of Q1 2025

New Positions

1

Closed Positions

2

Increased

1

Decreased

4

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BML Capital Management, LLC$1.2M2,093,232
2OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)$148K268,946
3CHOREO, LLC$88K160,867
4RENAISSANCE TECHNOLOGIES LLC$63K114,800
5Callan Capital, LLC$44K80,000
6ROYAL BANK OF CANADA$22K40,400
7GEODE CAPITAL MANAGEMENT, LLC$15K27,961
8COMMONWEALTH EQUITY SERVICES, LLC$11K20,000
9ADAR1 Capital Management, LLCNew$6K10,300
10UBS Group AG$5K8,739

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CNTB?

As of Q1 2025, 13 institutional investors report holding CNTB (Connect Biopharma Holdings Limited) in their 13F filings.

Which hedge fund owns the most CNTB?

The largest institutional holder of CNTB is BML Capital Management, LLC with $1.2M in shares.

Are institutions buying or selling CNTB?

This quarter, 1 institutions opened new positions in CNTB and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.